Biomarker-based prediction of inflammatory bowel disease-related colorectal cancer: a case-control study.

Background Regular colonoscopic surveillance for detection of dysplasia is recommended in longstanding inflammatory bowel disease (IBD), however, its sensitivity is disputed. Screening accuracy may increase by using a biomarker-based surveillance strategy.